FDA-filed SPL labeling · retrieved through openFDA

Enoxaparin

Enoxaparin is a blood thinner (anticoagulant) used to prevent and treat dangerous blood clots, including deep vein thrombosis, pulmonary embolism, and clot-related complications of unstable angina and heart attack.

Brand name Lovenox
Drug classes ⓘ Heparin
Rx Form 1 Routes Subcutaneous · Intravenous; Subcutaneous · Intravenous, Subcutaneous
Dr. Brian Staiger, PharmD, BCPS
Reviewed by Last reviewed Jul 10, 2026
🧬 Where this information comes from Click to expand

The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 30 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →

At a glance
Linked label effectiveApr 27, 2026
Clinical labels in scope ⓘ30
AvailabilityRx
Earliest approval/marketing year ⓘ1993
FDA-listed product records ⓘ428
Boxed warningYes
How we combine label and product data →
✓No current FDA shortage listed · checked Sep 19, 2026 🚨Recall on record
Other forms & routes:
Injection
⭐ Enoxaparin at a glance The quick version — the full detail is in the Patient Information Guide below.
💊
HelloPharmacist Editorial Team Bottom Line
Enoxaparin is a highly effective injectable blood thinner used to prevent and treat serious blood clots, including DVT, pulmonary embolism, and clot complications from heart attacks and unstable angina. It requires careful monitoring for bleeding, and the timing around any spinal procedure is critical — always keep your entire medical team informed that you are taking it. Follow your prescriber's instructions exactly and never stop or adjust the dose on your own.
How we write & review this content — our editorial policy →
⚠️ FDA Boxed Warning — the FDA’s strongest safety alert ▾

Serious warning: Enoxaparin can cause dangerous bleeding inside the spine. If you receive enoxaparin while also getting spinal or epidural anesthesia, or having a spinal puncture (spinal tap), there is a risk of bleeding into the space around your spinal cord — called a spinal or epidural hematoma. This can press on your spinal cord and cause long-term or permanent paralysis.

Your risk is higher if you have an indwelling epidural catheter (a tube left in your spine for pain control), take other drugs that affect bleeding (like NSAIDs, aspirin, or other blood thinners), have had multiple or difficult spinal procedures in the past, or have a history of spinal surgery or a spinal deformity. Watch for new numbness or weakness in your legs, loss of bladder or bowel control, or back pain — and get emergency medical help immediately if any of these occur.

Read the full warning on DailyMed →

📖 Enoxaparin: Patient Information Guide

A plain-language walkthrough of Enoxaparin — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.

🎯What it's used for▾

Enoxaparin is a low molecular weight heparin (LMWH) approved for several blood clot-related conditions across multiple products and formulations.

  • Prevention of deep vein thrombosis (DVT): For patients having abdominal surgery, hip replacement surgery, or knee replacement surgery who are at risk for clots; also for hospitalized medical patients whose movement is severely restricted during acute illness
  • Treatment of acute DVT with pulmonary embolism (inpatient): Enoxaparin Sodium Injection and Lovenox are used alongside warfarin for inpatient DVT treatment, with or without a pulmonary embolism
  • Treatment of acute DVT without pulmonary embolism (outpatient): Enoxaparin Sodium Injection and Lovenox are used alongside warfarin for outpatient DVT treatment when there is no pulmonary embolism
  • Prevention of ischemic complications of unstable angina and non-Q-wave myocardial infarction: Enoxaparin Sodium Injection and Lovenox are given with aspirin to reduce the risk of dangerous tissue damage from reduced blood flow in these cardiac conditions
  • Treatment of acute STEMI (ST-segment elevation myocardial infarction): Enoxaparin Sodium Injection and Lovenox are used for STEMI managed medically or with percutaneous coronary intervention (PCI)
⚙️How it works▾

Enoxaparin works by blocking clotting proteins in the blood — most importantly a protein called Factor Xa — which disrupts the clotting cascade and prevents dangerous blood clots from forming or getting larger. Compared to regular heparin, enoxaparin has a much stronger effect on Factor Xa relative to its effect on thrombin (another clotting protein), which gives it a more predictable, targeted anticoagulant effect.

💊How it's taken▾

Enoxaparin is given as an injection — most commonly under the skin (subcutaneously) — once or twice a day, depending on what it's being used for. In certain heart attack situations, an initial dose may be given directly into a vein (intravenously) followed by subcutaneous injections. It can be given regardless of meals since it's injected, not swallowed.

  • Timing of doses around surgery, spinal procedures, or epidural catheters is especially important — your medical team will set this carefully
  • Never skip or double up on doses without guidance from your prescriber
  • Follow your prescriber's and pharmacist's instructions exactly for your specific condition and product
🤒Side effects — in detail▾

The most common side effects of enoxaparin relate to its blood-thinning action:

  • Bleeding (can range from minor bruising to serious internal bleeding)
  • Anemia (low red blood cell count)
  • Low platelet count (thrombocytopenia)
  • Elevated liver enzymes (detected on blood tests)
  • Nausea or diarrhea
  • Bruising or pain at the injection site
  • Fever or swelling (edema)
  • Shortness of breath (dyspnea) or confusion

Serious reactions — including spinal hematoma (bleeding around the spinal cord), severe allergic reactions, and significant internal bleeding — require emergency medical attention. Call 911 or go to the ER immediately if you experience sudden leg weakness, numbness, or loss of bladder/bowel control.

⚠️Warnings & precautions▾

Spinal/epidural hematoma (bleeding around the spinal cord) is the most critical risk. This can occur if you receive enoxaparin while having spinal anesthesia or a spinal tap, potentially causing long-term paralysis. The risk is higher with epidural catheters, certain other medications, or a history of spinal problems. Watch for sudden back pain, weakness, numbness, or loss of bladder/bowel control — and seek emergency care immediately.

  • Bleeding risk: Enoxaparin increases the risk of bleeding throughout the body. Monitor for unusual bruising, prolonged bleeding, blood in urine or stool, or coughing/vomiting blood
  • Heparin-induced thrombocytopenia (HIT): A rare but serious immune reaction that causes a dangerous drop in platelets and can paradoxically cause clots; enoxaparin must not be used in patients with a history of HIT within 100 days or with circulating HIT antibodies
  • Not interchangeable: Enoxaparin cannot be swapped with regular heparin or other LMWHs without close medical supervision
  • Mechanical heart valves in pregnancy: Pregnant women with mechanical prosthetic heart valves face an elevated risk of blood clots; extra monitoring and dose adjustment are required
  • Kidney disease: Reduced kidney function slows clearance of enoxaparin, increasing bleeding risk; dose adjustment is needed for severe renal impairment
🔀What it interacts with▾

Several medications can increase the bleeding risk when taken with enoxaparin — tell your doctor and pharmacist about everything you take:

  • Other anticoagulants (blood thinners): Adding another blood thinner significantly raises bleeding risk
  • NSAIDs (ibuprofen, naproxen, ketorolac): These anti-inflammatory drugs affect platelet function and increase the chance of serious bleeding
  • Aspirin and other salicylates: Even low-dose aspirin adds to bleeding risk; used intentionally in some cardiac indications, but always under medical supervision
  • Platelet inhibitors (dipyridamole, clopidogrel, and similar drugs): These reduce platelet clotting and compound enoxaparin's effects
  • Sulfinpyrazone (gout medication): Can enhance hemorrhage risk when combined with enoxaparin

This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.

📋Before taking it▾
  • Active major bleeding: Enoxaparin is contraindicated — do not use it if you are currently having significant bleeding
  • History of HIT (heparin-induced thrombocytopenia): Must not use enoxaparin if you had HIT within the last 100 days or have circulating HIT antibodies
  • Allergies: Do not use if allergic to enoxaparin, heparin, pork products, or benzyl alcohol (the multiple-dose vial contains benzyl alcohol)
  • Severe kidney disease: Dose adjustment is required; your prescriber needs to know your kidney function
  • Pregnancy with mechanical heart valves: Significant added risk of clotting for mother and baby; requires intensive monitoring
  • Upcoming spinal procedures or epidural anesthesia: Timing of enoxaparin doses must be carefully coordinated with your anesthesiologist and surgeon
  • Older adults: May have reduced kidney clearance leading to higher drug exposure; prescribers should account for this
  • Bleeding disorders: Patients should be evaluated for bleeding problems before starting enoxaparin
🚑If you take too much▾

Too much enoxaparin can lead to serious bleeding. If an overdose occurs, a medication called protamine sulfate can be given intravenously to partially reverse enoxaparin's effects — but it never fully neutralizes it, and it carries its own serious risks including severe low blood pressure and allergic reactions. Seek emergency medical care immediately if an overdose is suspected.

📡Pharmacodynamics — effects in the body▾

Enoxaparin slows the body's blood clotting system by strongly inhibiting Factor Xa (a key clotting protein) while having a lesser effect on thrombin (Factor IIa) — giving it a more targeted action than regular heparin. It measurably prolongs clotting times, including the activated partial thromboplastin time (aPTT), though the aPTT effect is more modest than with standard heparin. These combined effects reduce the blood's tendency to form dangerous clots while keeping clotting ability partially intact.

🔬Pharmacokinetics — how your body processes it▾

After a subcutaneous (under-the-skin) injection, enoxaparin reaches its peak blood-thinning activity in about 3 to 5 hours, and its effects last roughly 12 hours after a once-daily dose. It is processed mainly by the liver and cleared primarily through the kidneys, so people with reduced kidney function can have higher drug levels. The elimination half-life (the time for half the drug to leave the body) is approximately 4.5 hours after a single dose and up to about 7 hours with repeated dosing. When given intravenously, the drug acts more quickly, and steady drug levels in the blood are typically reached within the first 1 to 2 days of treatment.

📦How to store it▾

Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° and 30°C (59° and 86°F). Store in the original carton or packaging until ready to use. Keep out of the reach of children.

📄 Written from Enoxaparin’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →

🩺 Pharmacist Counseling Corner

Quick, plain-English answers to the questions patients ask most about Enoxaparin — the kind of thing our pharmacy team would talk through with you at the counter.

Why do I have to give myself shots instead of taking a pill? ▾
Enoxaparin has to be injected because it can't be absorbed properly when swallowed. The good news is the needle is very small, and most people get comfortable with the technique quickly. Your nurse or pharmacist can walk you through exactly how to do it — usually in the belly area, rotating spots each time to avoid soreness.
What should I watch for that means I need to call my doctor or go to the ER? ▾
The biggest thing to watch for is unusual bleeding — that includes cuts that won't stop, blood in your urine or stool, vomiting blood, or coughing up blood. Even more urgent: if you've recently had a spinal procedure or epidural and you feel sudden weakness, numbness in your legs, or lose control of your bladder or bowel, call 911 right away. That can be a sign of serious bleeding around your spinal cord and needs emergency care immediately.
Can I take ibuprofen or aspirin while I'm on this? ▾
You should avoid ibuprofen, naproxen, and similar anti-inflammatory drugs (NSAIDs) while on enoxaparin unless your doctor specifically approves it, because combining them significantly raises your bleeding risk. Aspirin is sometimes used intentionally with enoxaparin for heart conditions — but only under your doctor's direction. Always check with your prescriber or pharmacist before adding any over-the-counter pain reliever.
Is it safe to have surgery or a spinal injection while I'm taking enoxaparin? ▾
It can be done, but the timing has to be very carefully managed. Enoxaparin needs to be paused for a specific window of time before any spinal procedure or epidural anesthesia to lower the risk of dangerous bleeding into the spine. Make sure every doctor involved in your care — especially your anesthesiologist — knows you're on enoxaparin well before any planned procedure.
I've heard this is similar to heparin. Can I switch between them? ▾
No — enoxaparin is not interchangeable with regular heparin or other similar injectable blood thinners. They work differently and are dosed differently, so switching without careful medical guidance can be dangerous. If there's ever a need to change your blood thinner, your doctor will manage that transition closely.
Does kidney disease affect how this medication works for me? ▾
Yes, it does. Enoxaparin is partly cleared by your kidneys, so if your kidneys aren't working at full capacity, the drug can build up in your body and increase your bleeding risk. If you have kidney disease, your prescriber may adjust your dose or monitor you more closely. Make sure your care team knows your kidney status before you start treatment.
Is Enoxaparin available over the counter? ▾
Enoxaparin is dispensed by prescription according to its FDA labeling, so it isn't sold over the counter. Your prescriber and pharmacist will determine if it's appropriate for you.
When was Enoxaparin first available? ▾
Enoxaparin has been available in the United States since at least 1993, based on FDA approval history (Drugs@FDA) and product marketing records.
Who makes Enoxaparin? ▾
Enoxaparin is supplied by 30 manufacturers listed in the FDA NDC Directory, including Fresenius Kabi USA, LLC, Meitheal Pharmaceuticals Inc., Sanofi-Aventis U.S. LLC.

💬 Answers drafted from Enoxaparin’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →

🧰 Keep exploring

🌿Drug & Supplement CheckerEnoxaparin vs. vitamins & herbs 💬Ask a PharmacistFree answer, usually < 24h 🔎NDC & pricing lookupFind Enoxaparin NDCs & costs 🅰️Browse Drugs A–ZLook up any medication

💊 How Enoxaparin comes

Enoxaparin is available in 1 form. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.

Injection

Into a vein · Under the skin
Brands Lovenox
How this form is used
What it may be used for
  • Enoxaparin Sodium Injection and Lovenox are used to prevent DVT in patients having abdominal, hip, or knee replacement surgery, or in hospitalized patients with severely limited mobility
  • Enoxaparin Sodium Injection and Lovenox are used to treat acute DVT with or without pulmonary embolism (inpatient), or DVT without pulmonary embolism (outpatient), given alongside warfarin
  • Enoxaparin Sodium Injection and Lovenox are used to reduce the risk of ischemic complications in unstable angina and non-Q-wave myocardial infarction, given with aspirin
  • Enoxaparin Sodium Injection and Lovenox are used to treat acute STEMI (a serious type of heart attack) managed medically or with percutaneous coronary intervention (PCI)
Important instructions
  • Enoxaparin Sodium Injection and Lovenox are given by subcutaneous (under-the-skin) injection for most uses; an intravenous (IV) route is used for the initial dose in STEMI treatment
  • Enoxiluv Kit contains enoxaparin sodium for subcutaneous injection — follow the specific instructions included with the kit
  • Inject subcutaneously into the abdomen, thigh, or as directed; rotate injection sites to reduce bruising
  • Timing of doses around surgical procedures or spinal interventions is critical — always follow your prescriber's specific schedule
Available strengths 8 strengths
30 mg/0.3 mL 40 mg/0.4 mL 60 mg/0.6 mL 80 mg/0.8 mL 100 mg/mL 120 mg/0.8 mL
Show 2 more strengths Show fewer strengths
150 mg/mL 300 mg/3 mL
420 FDA-listed product records ⓘ

📊 Enoxaparin across the U.S. market

How Enoxaparin appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

1
Dose forms ⓘ
30
Manufacturers
2
Brand names
428
FDA-listed product records ⓘ
1993
First marketed ⓘ

Also listed with the FDA, not a patient dose form: Powder (8) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.

Fresenius Kabi USA, LLC18%
Meitheal Pharmaceuticals Inc.10%
Sanofi-Aventis U.S. LLC9%
Amphastar Pharmaceuticals, Inc.7%
Sandoz Inc7%
BluePoint Laboratories6%
Other makers43%

Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

📈 How widely Enoxaparin is used

A general measure of how commonly Enoxaparin is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.

Think of this as a proxy for how widely Enoxaparin is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.

263,205
Medicaid prescriptions filled (Q1–Q4 2025)
$33.2M gross Medicaid reimbursement (before mandatory rebates — net cost is lower)

How commonly is Enoxaparin prescribed? Of the 1,596 medications we measure, Enoxaparin ranks #343 by Medicaid prescriptions — more than 79% of them.

Where Enoxaparin ranks among the drugs we measure · Q1–Q4 2025 · neighbors ±5
Total prescriptions — #343 of 1,596
#338 Colchicine 278,344 Rx #339 Beclomethasone Oral In... 276,319 Rx #340 Umeclidinium and Vilan... 275,927 Rx #341 Liraglutide Injection 264,561 Rx #342 Ammonium Lactate Topic... 263,246 Rx #343 Enoxaparin Injection 263,205 Rx #344 Enoxaparin 263,205 Rx #345 Levonorgestrel 262,844 Rx #346 Nabumetone 262,800 Rx #347 Evolocumab Injection 262,375 Rx #348 Dorzolamide / Timolol 260,759 Rx

Utilization by Enoxaparin product

Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.

The 0.4 mL / 100 mg/mL prefilled syringe is the most-dispensed Enoxaparin product — about 64% of these Medicaid prescriptions.

0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe Most dispensed

167,523 Medicaid prescriptions (Q1–Q4 2025) 64% of Enoxaparin prescriptions shown $13.7M gross reimbursement (before rebates) ≈ $82 per prescription (gross)

Summed across the 19 of 53 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 854235

1 ML enoxaparin sodium 100 MG/ML Prefilled Syringe

21,974 Medicaid prescriptions (Q1–Q4 2025) 8% of Enoxaparin prescriptions shown $5.5M gross reimbursement (before rebates) ≈ $251 per prescription (gross)

Summed across the 14 of 48 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 854248

0.8 ML enoxaparin sodium 100 MG/ML Prefilled Syringe

21,593 Medicaid prescriptions (Q1–Q4 2025) 8% of Enoxaparin prescriptions shown $4.9M gross reimbursement (before rebates) ≈ $226 per prescription (gross)

Summed across the 12 of 49 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 854241

0.6 ML enoxaparin sodium 100 MG/ML Prefilled Syringe

18,238 Medicaid prescriptions (Q1–Q4 2025) 7% of Enoxaparin prescriptions shown $3M gross reimbursement (before rebates) ≈ $162 per prescription (gross)

Summed across the 14 of 48 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 854238

0.3 ML enoxaparin sodium 100 MG/ML Prefilled Syringe

12,998 Medicaid prescriptions (Q1–Q4 2025) 5% of Enoxaparin prescriptions shown $1.1M gross reimbursement (before rebates) ≈ $83 per prescription (gross)

Summed across the 15 of 48 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 854228

0.8 ML enoxaparin sodium 150 MG/ML Prefilled Syringe

9,647 Medicaid prescriptions (Q1–Q4 2025) 4% of Enoxaparin prescriptions shown $2.9M gross reimbursement (before rebates) ≈ $303 per prescription (gross)

Summed across the 13 of 46 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 854245

enoxaparin sodium 100 MG/ML Injectable Solution

7,257 Medicaid prescriptions (Q1–Q4 2025) 3% of Enoxaparin prescriptions shown $603,906 gross reimbursement (before rebates) ≈ $83 per prescription (gross)

Summed across the 7 of 13 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 854255

1 ML enoxaparin sodium 150 MG/ML Prefilled Syringe

3,975 Medicaid prescriptions (Q1–Q4 2025) 2% of Enoxaparin prescriptions shown $1.5M gross reimbursement (before rebates) ≈ $378 per prescription (gross)

Summed across the 9 of 46 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 854252

Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.

Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Enoxaparin, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 103 of 351 listed Enoxaparin NDCs with Medicaid activity.

🔍 Compare Enoxaparin products

A representative set of FDA-listed product records for Enoxaparin — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)

Showing 200 of 428 products — FDA National Drug Code Directory. See every product, package size and price: browse all 428 Enoxaparin NDCs →

RxNorm Concept Web — From Ingredient to Every Form and Strength

This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.

Ingredient (IN) Enoxaparin RxCUI 67108 2 dose forms · 8 strengths
  1. Dose form (SCDF) Injectable Solution RxCUI 372012 In current FDA listings
    Clinical drug / strength (SCD) sodium 100 MG/ML RxCUI 854255

Look up RxCUI 67108 in the RxCUI Atlas →

RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.

🏷️ Sold under these brand names

Lovenox

🏭 Manufacturers & labelers

Fresenius Kabi USA, LLC 77 Meitheal Pharmaceuticals Inc. 43 Sanofi-Aventis U.S. LLC 39 Amphastar Pharmaceuticals, Inc. 31 Sandoz Inc 28 BluePoint Laboratories 24 Zydus Pharmaceuticals USA Inc. 21 NorthStar Rx LLC 21 Cardinal Health 107, LLC 16 Gland Pharma Limited 14 Hepalink USA Inc. 14 BE Pharmaceuticals Inc. 14 NorthStar RxLLC 14 Apotex Corp. 14 Cardinal Health 12 Hebei Changshan Biochemical Pharmaceutical Co., Ltd. 8 Winthrop U.S. 8 Winthrop U.S, a business of sanofi-aventis U.S. LLC 8 Italfarmaco SpA 7 Teva Parenteral Medicines, Inc. 3 Sagent Pharmaceuticals 2 Shenzhen Techdow Pharmaceutical Co., Ltd. 2 A-S Medication Solutions 1 Shenzhen Hepalink Pharmaceutical Group Co., Ltd. 1

…and 6 more on the FDA NDC directory.

RxNorm drug class

Enoxaparin belongs to the Low Molecular Weight Heparin class.

Pharmacologic class Low Molecular Weight Heparin
Drug family (ATC) Heparin group

Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.

🔬 Where this comes from

Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.

📄
FDA-filed drug labels (SPL) Uses, dosing, warnings & side effects from SPL records retrieved through openFDA; the linked representative set can be verified on DailyMed. ✓ Linked label effective Apr 27, 2026
🏭
Forms, brands & labelersAggregated from ingredient-matched FDA National Drug Code Directory product records for Enoxaparin.
📈
Real-world reportsThe FDA Adverse Event Reporting System (FAERS), served through openFDA.
🚨
Recalls & shortagesopenFDA drug-enforcement reports and the FDA drug-shortage database.
🧾 Clinical label set — FDA-filed SPL labels retained for Enoxaparin after exact ingredient or ingredient-combination matching and applicable route/form matching
Clinical labels in scope
30
NDC products indexed
428
Distinct labelers/manufacturers represented
30
Linked representative label ⓘ
Cardinal Health
Linked label effective
Apr 27, 2026
Composite sections available
23
Linked SPL Set ID
3d263380-4f44-4fd8-aa2a-e69702ab258f
Linked SPL Document ID
ebd70650-9a1a-4922-859c-d14448c43c70
Open the linked representative label on DailyMed ↗

How we combine label and product data

HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 30 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.

For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. Cardinal Health is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.

This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.